Follow
Jayanta B Sarma
Jayanta B Sarma
Northumbria Healthcare NHS Foundation Trust
Verified email at nhs.net
Title
Cited by
Cited by
Year
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study
KK Kumarasamy, MA Toleman, TR Walsh, J Bagaria, F Butt, ...
The Lancet infectious diseases 10 (9), 597-602, 2010
41462010
Phylogenetic diversity of Escherichia coli strains producing NDM-type carbapenemases
S Mushtaq, S Irfan, JB Sarma, M Doumith, R Pike, J Pitout, DM Livermore, ...
Journal of antimicrobial chemotherapy 66 (9), 2002-2005, 2011
2172011
Prevalence of blaTEM, blaSHV and blaCTX-M genes in clinical isolates of Escherichia coli and Klebsiella pneumoniae from Northeast India
A Bora, NK Hazarika, SK Shukla, KN Prasad, JB Sarma, G Ahmed
Indian journal of Pathology and Microbiology 57 (2), 249-254, 2014
952014
Co-morbidities as predictors of mortality in Clostridium difficile infection and derivation of the ARC predictive score
MR Welfare, LC Lalayiannis, KE Martin, S Corbett, B Marshall, JB Sarma
Journal of Hospital Infection 79 (4), 359-363, 2011
822011
Multidrug-resistant Enterobacteriaceae including metallo-β-lactamase producers are predominant pathogens of healthcare-associated infections in an Indian teaching hospital
JB Sarma, PK Bhattacharya, D Kalita, M Rajbangshi
Indian journal of medical microbiology 29 (1), 22-27, 2011
762011
Daptomycin for the treatment of osteomyelitis and orthopaedic device infections: real-world clinical experience from a European registry
K Malizos, J Sarma, RA Seaton, M Militz, F Menichetti, G Riccio, ...
European Journal of Clinical Microbiology & Infectious Diseases 35, 111-118, 2016
602016
Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis
JB Sarma, B Marshall, V Cleeve, D Tate, T Oswald, S Woolfrey
Journal of Hospital Infection 91 (1), 74-80, 2015
552015
Effects of fluoroquinolone restriction (from 2007 to 2012) on resistance in Enterobacteriaceae: interrupted time-series analysis
JB Sarma, B Marshall, V Cleeve, D Tate, T Oswald, S Woolfrey
Journal of Hospital Infection 91 (1), 68-73, 2015
512015
Thirty-day mortality of Clostridium difficile infection in a UK National Health Service Foundation Trust between 2002 and 2008
AP McGowan, LC Lalayiannis, JB Sarma, B Marshall, KE Martin, ...
Journal of Hospital Infection 77 (1), 11-15, 2011
492011
Incidence of blaNDM-1 gene in Escherichia coli isolates at a tertiary care referral hospital in Northeast India
A Bora, GU Ahmed, NK Hazarika, KN Prasad, SK Shukla, V Randhawa, ...
Indian journal of medical microbiology 31 (3), 250-256, 2013
472013
Infection control with limited resources: why and how to make it possible?
JB Sarma, GU Ahmed
Indian Journal of Medical Microbiology 28 (1), 11-16, 2010
452010
Characterisation of methicillin resistant S. aureus strains and risk factors for acquisition in a teaching hospital in northeast India
JB Sarma, GU Ahmed
Indian Journal of Medical Microbiology 28 (2), 127-129, 2010
442010
Daptomycin in the Clinical Setting: 8-Year Experience with Gram-positive Bacterial Infections from the EU-CORESM Registry
A Gonzalez-Ruiz, P Gargalianos-Kakolyris, A Timerman, J Sarma, ...
Advances in Therapy 32, 496-509, 2015
332015
Prevalence and risk factors for colonisation with extended spectrum β-lactamase producing enterobacteriacae vis-à-vis usage of antimicrobials
JB Sarma, GU Ahmed
Indian Journal of Medical Microbiology 28 (3), 217-220, 2010
162010
Synthesis, characterization and in vitro antimicrobial evaluation of some novel benzimidazole derivatives bearing hydrazone moiety
J Sarma, G Singh, M Gupta, R Gupta, B Kapoor
Asian J. Pharm. Clin. Res 10, 1-6, 2017
102017
Risk Factors for Mortality in Patients With Clostridium difficile Infection To the Editor—We read with great interest the recent article by Morrison
R Huttunen, J Aittoniemi, S Corbett, B Marshall, JB Sarma
infection 170, 784-90, 2010
102010
Antibiotic Stewardship und Hygiene–2 Seiten einer Medaille
P Gastmeier
AINS-Anästhesiologie· Intensivmedizin· Notfallmedizin· Schmerztherapie 52 …, 2017
72017
Impact of universal screening on MRSA bacteremias in a single acute NHS organisation (2006–12): interrupted time-series analysis
JB Sarma, B Marshall, V Cleeve, D Tate, T Oswald
Antimicrobial resistance and infection control 2, 1-11, 2013
72013
New Delhi metallo-β-lactamase 1–Authors' reply
TR Walsh, MA Toleman, JB Sarma, S Irfan, N Woodford, DM Livermore
The Lancet Infectious Diseases 10 (11), 752-754, 2010
72010
Identifying Antibiotic Use Targets for the Management of Antibiotic Resistance Using an Extended-Spectrum β-Lactamase-Producing Escherichia coli Case: A …
MA Aldeyab, SE Bond, BR Conway, J Lee-Milner, JB Sarma, WJ Lattyak
Antibiotics 11 (8), 1116, 2022
62022
The system can't perform the operation now. Try again later.
Articles 1–20